Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia

Psychiatry Research

Volumn 209, Issue 3, 2013, Pages 273-278

  Koola, Maju Mathew ^a,b   Boggs, Douglas Lee ^a,c   Kelly, Deanna Lynn ^a   Liu, Fang ^a   Linthicum, Jared Allen ^a   Turner, Hailey Elaine ^a   McMahon, Robert Patrick ^a   Gorelick, David Alan ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SHEPPARD PRATT HEALTH SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Abstinence; Cannabis; Coping behavior; Drug withdrawal symptoms; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CANNABIS SMOKING; COGNITIVE DEFECT; COPING BEHAVIOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARIJUANA QUIT QUESTIONNAIRE; PRIORITY JOURNAL; QUESTIONNAIRE; RELAPSE; SCHIZOPHRENIA; SMOKING CESSATION; SOCIAL AVOIDANCE BEHAVIOR; SOCIAL SUPPORT; SPIRITUAL CARE; WITHDRAWAL SYNDROME;

ABSTINENCE; CANNABIS; COPING BEHAVIOR; DRUG WITHDRAWAL SYMPTOMS; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MARIJUANA ABUSE; MIDDLE AGED; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUBSTANCE WITHDRAWAL SYNDROME; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84885474949     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.07.044     Document Type: Article

References (44)

1. Allsop D.J., Norberg M.M., Copeland J., Fu S., Budney A.J. The cannabis withdrawal scale development: patterns and predictors of cannabis withdrawal and distress. Drug and Alcohol Dependence 2011, 119:123-129.
2. Allsop D.J., Copeland J., Norberg M.M., Fu S., Molnar A., Lewis J., Budney A.J. Quantifying the clinical significance of cannabis withdrawal. PLoS One 2012, 7:e44864.
3. Barnett J.H., Werners U., Secher S.M., Hill K.E., Brazil R., Masson K., Pernet D.E., Kirkbride J.B., Murray G.K., Bullmore E.T., Jones P.B. Substance use in a population-based clinic sample of people with first-episode psychosis. British Journal of Psychiatry 2007, 190:515-520.
4. Bartels S.J., Drake R.E., Wallach M.A., Freeman D.H. Characteristic hostility in schizophrenic outpatients. Schizophrenia Bulletin 1991, 17:163-171.
5. Boggs D.L., Kelly D.L., Liu F., Linthicum J.A., Turner H., Schroeder J.R., McMahon R.P., Gorelick D.A. Cannabis withdrawal in chronic cannabis users with schizophrenia. Journal of Psychiatric Research 2013, 47:240-245.
6. Boyd S.J., Tashkin D.P., Huestis M.A., Heishman S.J., Dermand J.C., Simmons M.S., Gorelick D.A. Strategies for quitting among non-treatment-seeking marijuana smokers. The American Journal on Addictions 2005, 14:35-42.
7. Budney A.J. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue?. Addiction 2006, 101(1):125-133.
8. Budney A.J., Hughes J.R. The cannabis withdrawal syndrome. Current Opinion in Psychiatry 2006, 19:233-238.
9. Budney A.J., Hughes J.R., Moore B.A., Novy P.L. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Archives of General Psychiatry 2001, 58:917-924.
10. Budney A.J., Hughes J.R., Moore B.A., Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry 2004, 161:1967-1977.
11. Budney A.J., Moore B.A., Vandrey R.G., Hughes J.R. The time course and significance of cannabis withdrawal. Journal of Abnormal Psychology 2003, 112:393-402.
12. Carey K.B., Maisto S.A., Carey M.P., Purnine D.M. Measuring readiness-to-change substance misuse among psychiatric outpatients: I. Reliability and validity of self-report measures. Journal of Studies on Alcohol and Drugs 2001, 62:79-88.
13. Copersino M.L., Boyd S.J., Tashkin D.P., Huestis M.A., Heishman S.J., Dermand J.C., Simmons M.S., Gorelick D.A. Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. The American Journal on Addictions 2006, 15:297-302.
14. DeRenzo E.G., Conley R.R., Love R. Assessment of capacity to give consent to research participation: state-of-the-art and beyond. Journal of Health Politics, Policy and Law 1998, 1:66-87.
15. Dickerson F.B., Brown C.H., Kreyenbuhl J.A., Fang L., Goldberg R.W., Wohlheiter K., Dixon L.B. Obesity among individuals with serious mental illness. Acta Psychiatrica Scandinavica 2006, 113:306-313.
16. Ensminger M.E., Juon H.S., Green K.M. Consistency between adolescent reports and adult retrospective reports of adolescent marijuana use: explanations of inconsistent reporting among an African American population. Drug and Alcohol Dependence 2007, 89:13-23.
17. Fendrich M., Mackesy-Amiti M.E. Inconsistencies in lifetime cocaine and marijuana use reports: impact on prevalence and incidence. Addiction 1995, 90:111-118.
18. Fowler I.L., Carr V.J., Carter N.T., Lewin T.J. Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin 1998, 24:443-455.
19. Georgotas A., Zeidenberg P. Observations on the effects of four weeks of heavy marihuana smoking on group interaction and individual behavior. Comprehensive Psychiatry 1979, 20:427-432.
20. Grech A., Van Os J., Jones P.B., Lewis S.W., Murray R.M. Cannabis use and outcome of recent onset psychosis. European Psychiatry 2005, 20:349-353.
21. Green A.I., Tohen M.F., Hamer R.M., Strakowski S.M., Lieberman J.A., Glick I., Clark W.S. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophrenia Research 2004, 66:125-135.
22. Green B., Young R., Kavanagh D. Cannabis use and misuse prevalence among people with psychosis. British Journal of Psychiatry 2005, 187:306-313.
23. Haney M., Ward A.S., Comer S.D., Foltin R.W., Fischman M.W. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 1999, 141:395-404.
24. Hasin D.S., Keyes K.M., Alderson D., Wang S., Aharonovich E., Grant B.F. Cannabis withdrawal in the United States: results from NESARC. Journal of Clinical Psychiatry 2008, 69:1354-1363.
25. Humfleet G.L., Haas A.L. Is marijuana use becoming a 'gateway' to nicotine dependence?. Addiction 2004, 99:5-6.
26. Jones R.T., Benowitz N.L., Herning R.I. Clinical relevance of cannabis tolerance and dependence. Journal of Clinical Pharmacology 1981, 21:143S-152S.
27. Koola M.M., Wehring H.J., Kelly D.L. The potential role of long-acting injectable antipsychotics in people with schizophrenia and comorbid substance use. Journal of Dual Diagnosis 2012, 8:50-61.
28. Koola M.M., McMahon R.P., Wehring H.J., Liu F., Mackowick K.M., Warren K.R., Feldman S., Shim J.C., Love R.C., Kelly D.L. Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders. Journal of Psychiatric Research 2012, 46:987-993.
29. Koskinen J., Lohonen J., Koponen H., Isohanni M., Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin 2010, 36:1115-1130.
30. Kouri E.M., Pope H.G. Abstinence symptoms during withdrawal from chronic marijuana use. Experimental and Clinical Psychopharmacology 2000, 8:483-492.
31. Large M., Sharma S., Compton M.T., Slade T., Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Archives of General Psychiatry 2011, 68:555-561.
32. Levin K.H., Copersino M.L., Heishman S.J., Liu F., Kelly D.L., Boggs D.L., Gorelick D.A. Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug and Alcohol Dependence 2010, 111:120-127.
33. Linszen D.H., Dingemans P.M., Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 1994, 51:273-279.
34. Mennes C.E., Ben Abdallah A., Cottler L.B. The reliability of self-reported cannabis abuse, dependence and withdrawal symptoms: multisite study of differences between general population and treatment groups. Addictive Behaviors 2009, 34:223-226.
35. Milin R., Manion I., Dare G., Walker S. Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study. Journal of the American Academy of Child and Adolescent Psychiatry 2008, 47:174-178.
36. Nowlan R., Cohen S. Tolerance to marijuana: heart rate and subjective "high". Clinical Pharmacology and Therapeutics 1977, 22:550-556.
37. Patton G.C., Coffey C., Carlin J.B., Sawyer S.M., Lynskey M. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction 2005, 100:1518-1525.
38. Sigmon S.C., Steingard S., Badger G.J., Anthony S.L., Higgins S.T. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study. Experimental and Clinical Psychopharmacology 2000, 8:509-517.
39. Sobell M.B., Sobell L.C., Leo G.I. Does enhanced social support improve outcomes for problem drinkers in guided self-change treatment?. Journal of Behavior Therapy and Experimental Psychiatry 2000, 31:41-54.
40. Vandrey R.G., Budney A.J., Hughes J.R., Liguori A. A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug and Alcohol Dependence 2008, 92:48-54.
41. Veen N.D., Selten J.P., van der Tweel I., Feller W.G., Hoek H.W., Kahn R.S. Cannabis use and age at onset of schizophrenia. The American Journal of Psychiatry 2004, 161:501-506.
42. Volkow N.D. Substance use disorders in schizophrenia-clinical implications of comorbidity. Schizophrenia Bulletin 2009, 35:469-472.
43. Walters G.D. Spontaneous remission from alcohol, tobacco, and other drug abuse: seeking quantitative answers to qualitative questions. American Journal of Drug and Alcohol Abuse 2000, 26:443-460.
44. Wiesbeck G.A., Schuckit M.A., Kalmijn J.A., Tipp J.E., Bucholz K.K., Smith T.L. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction 1996, 91:1469-1478.